Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2023 | (FY)Mar 31, 2022 | |
---|---|---|
Total revenue | 16.85%4.6B | 3.94B |
Cost of revenue | 11.31%3.06B | 2.75B |
Gross profit | 29.67%1.54B | 1.19B |
Operating expense | 14.33%1.09B | 955.07M |
Operating profit | 92.57%448.45M | 232.88M |
Net non-operating interest income (expenses) | 1.86%-22.36M | -22.78M |
Non-operating interest income | -5.56%17K | --18K |
Non-operating interest expense | -1.86%22.37M | --22.8M |
Net investment income | 22,714.29%1.6M | 7K |
Gain(Loss) on financial instruments designated as cash flow hedges | ||
Gain(Loss) on derecognition of available-for-sale financial assets | ||
Income from associates and other participating interests | ||
Special income (charges) | 58.19%-20.92M | -50.04M |
Less:Other special charges | -39.57%-28.12M | ---20.15M |
Less:Write off | -30.13%49.04M | --70.18M |
Other non-operating income (expenses) | 161.38%213K | -347K |
Income before tax | 154.81%406.99M | 159.72M |
Income tax | 205.89%127.7M | 41.75M |
Net income | 136.74%279.29M | 117.98M |
Net income continuous operations | 136.74%279.29M | --117.98M |
Noncontrolling interests | ||
Net income attributable to the company | 136.73%279.29M | 117.98M |
Preferred stock dividends | ||
Other under preferred stock dividend | 0 | 0 |
Net income attributable to common stockholders | 136.73%279.29M | 117.98M |
Gross dividend payment | ||
Basic earnings per share | 136.73%209.3613 | 88.437 |
Diluted earnings per share | 136.73%209.3613 | 88.437 |
Dividend per share | ||
Currency Unit | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP |